In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

被引：2
|
作者：
Awar, Melina [1 ]
Mylonakis, Eleftherios [1 ]
机构：
[1] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 06期
关键词：
D O I：
10.7326/J23-0039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Source Citation Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161 Clinical Impact Ratings GIM/FP/GP: GIM/FP/GP: Geriatrics: Infectious Disease: Pulmonology: Public Health:
引用
收藏
页码：JC63 / JC63
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults
    Falsey, Ann R.
    Williams, Kristi
    Gymnopoulou, Efi
    Bart, Stephan
    Ervin, John
    Bastian, Arangassery R.
    Menten, Joris
    De Paepe, Els
    Vandenberghe, Sjouke
    Chan, Eric K. H.
    Sadoff, Jerald
    Douoguih, Macaya
    Callendret, Benoit
    Comeaux, Christy A.
    Heijnen, Esther
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (07): : 609 - 620
  • [2] PHASE 2B STUDY OF AN AD26.RSV.PREF VACCINE FOR PREVENTION OF RSV-MEDIATED RESPIRATORY TRACT DISEASE IN OLDER ADULTS
    Falsey, Ann
    Williams, Kristi
    Gymnopoulou, Efi
    Bart, Stephan
    Ervin, John
    De Paepe, Els
    Comeaux, Christy
    Heijnen, Esther
    INNOVATION IN AGING, 2021, 5 : 1042 - 1042
  • [3] Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-Dose Influenza Vaccine in Adults 65 Years and Older: A Noninferiority Trial
    Widagdo, Widagdo
    Bastian, Arangassery Rosemary
    Jastorff, Archana M.
    Scheys, Ilse
    De Paepe, Els
    Comeaux, Christy A.
    Ligtenberg, Nynke
    Callendret, Benoit
    Heijnen, Esther
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (02): : e374 - e383
  • [4] Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
    Bartsch, Yannic C.
    Cizmeci, Deniz
    Yuan, Dansu
    Mehta, Nickita
    Tolboom, Jeroen
    De Paepe, Els
    van Heesbeen, Roy
    Sadoff, Jerald
    Comeaux, Christy A.
    Heijnen, Esther
    Callendret, Benoit
    Alter, Galit
    Bastian, Arangassery Rosemary
    Gallagher, Tom
    JOURNAL OF VIROLOGY, 2023, 97 (11)
  • [5] Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults
    Sadoff, Jerald
    De Paepe, Els
    Haazen, Wouter
    Omoruyi, Edmund
    Bastian, Arangassery R.
    Comeaux, Christy
    Heijnen, Esther
    Strout, Cynthia
    Schuitemaker, Hanneke
    Callendret, Benoit
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (04): : 699 - 708
  • [6] Ad26.RSV.preF completely protects calves from severe respiratory disease induced by bovine RSV challenge
    van der Fits, Leslie
    de Jong, Rineke
    Dijkman, Karin
    Heemskerk-van der Meer, Marjolein
    Tettero, Lisanne
    Bonsing, Judith
    van Oort, Sophie
    Serroyen, Jan
    van Schie, Marianke
    Stockhofe-Zurwieden, Norbert
    Callendret, Benoit
    Zahn, Roland
    NPJ VACCINES, 2024, 9 (01)
  • [7] Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
    Wilson, Eleanor
    Goswami, Jaya
    Baqui, Abdullah H.
    Doreski, Pablo A.
    Perez-Marc, Gonzalo
    Zaman, Khalequ
    Monroy, Jorge
    Duncan, Christopher J. A.
    Ujiie, Mugen
    Raemet, Mika
    Perez-Breva, Lina
    Falsey, Ann R.
    Walsh, Edward E.
    Dhar, Rakesh
    Wilson, Lauren
    Du, Jiejun
    Ghaswalla, Parinaz
    Kapoor, Archana
    Lan, Lan
    Mehta, Shraddha
    Mithani, Runa
    Panozzo, Catherine A.
    Simorellis, Alana K.
    Kuter, Barbara J.
    Schoedel, Florian
    Huang, Wenmei
    Reuter, Caroline
    Slobod, Karen
    Stoszek, Sonia K.
    Shaw, Christine A.
    Miller, Jacqueline M.
    Das, Rituparna
    Chen, Grace L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24): : 2233 - 2244
  • [8] Use of an mRNA-based RSV-PreF vaccine in older adults
    Mellinghoff, Sibylle C.
    Cornely, Oliver A.
    Nitschmann, Sirka
    INNERE MEDIZIN, 2024, 65 (05): : 527 - 529
  • [9] Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life
    Hosman, Tessa
    van Heesbeen, Roy
    Bastian, Arangassery Rosemary
    Hu, Weihong
    Comeaux, Christy
    Ligtenberg, Nynke
    van Montfort, Bart
    Callendret, Benoit
    Heijnen, Esther
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [10] In older adults, an AS01E-adjuvanted RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease
    Awar, Melina
    Mylonakis, Eleftherios
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (06) : JC62 - JC62
12345